image
Healthcare - Biotechnology - NASDAQ - AU
$ 0.2911
-8.11 %
$ 5.68 M
Market Cap
-0.16
P/E
CASH FLOW STATEMENT
-9.62 M OPERATING CASH FLOW
32.33%
0 INVESTING CASH FLOW
0.00%
15.1 M FINANCING CASH FLOW
308.22%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Bionomics Limited
image
Net Income -15.5 M
Depreciation & Amortization 663 M
Capital Expenditures -4.44
Stock-Based Compensation 815 M
Change in Working Capital 1.45 M
Others -1.47 B
Free Cash Flow -14.7 M

Cash Flow

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016
OPERATING CASH FLOW
Net Income (15.5) (21.2) (15.0) (6.5) (4.9) (7.3) (18.6) (5.2) (12.4)
Depreciation & Amortization 663.0 0.8 0.8 1.3 1.5 1.0 1.2 1.3 1.4
Deferred Income Tax 0 (0.1) (0.1) (0.1) (0.2) (0.2) (0.8) (0.2) (0.3)
Stock Based Compensation 814.8 1.9 2.8 1.3 55.4 K 0 0 0.4 0.3
Other Operating Activities (1 473.4) 5.1 (2.6) (1.3) 1.0 (4.3) 2.2 2.7 (0.5)
Change in Working Capital 1.5 33.1 K 27 K 25.6 K (0.2) (0.2) 0.4 40.5 K (0.3)
Cash From Operations (9.6) (14.2) (15.0) (5.7) (2.7) (10.9) (15.1) (1.1) (11.4)
INVESTING CASH FLOW
Capital Expenditures 4.44 0 1.07 K 1.1 K 5.32 K 69.5 K (0.4) (0.2) (0.1)
Other Items 4.44 0.3 0.4 59 K (0.1) 0.2 0.4 0.9 1.0
Cash From Investing Activities 0 0.3 0.4 60.1 K (0.1) 0.1 60.1 K 0.7 0.8
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 (0.1) (8.9) (5.7) (3.7) 1.6 (1.7) 3.7
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 5.0 (2.5) (6.9) (0.3) (0.2) (0.4) 14.6 K 270 (0.5)
Cash From Financing Activities 15.1 3.7 18.6 23.7 (3.7) 3.1 1.9 (1.6) 24.7
CHANGE IN CASH
Net Change In Cash 0.5 (11.0) 1.8 18.2 (6.7) (8.6) (14.5) (0.9) 13.5
FREE CASH FLOW
Free Cash Flow (14.7) (14.2) (15.0) (5.7) (2.7) (11.0) (15.5) (1.3) (11.6)